Expression of tumor necrosis factor-α induced protein 8 like-2 contributes to the immunosuppressive property of CD4 +CD25 + regulatory T cells in mice

Molecular Immunology

Volumn 49, Issue 1-2, 2011, Pages 219-226

  Luan, Ying Yi ^a,b   Yao, Yong Ming ^a   Zhang, Lei ^c   Dong, Ning ^a   Zhang, Qing Hong ^a   Yu, Yan ^a   Sheng, Zhi Yong ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

^c General Hospital of the Second Artillery   (China)

Author keywords

Cell mediated immunity; Immunosuppression; Regulatory T cells; Tumor necrosis factor induced protein 8 like 2

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR NFAT; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INDUCED PROTEIN 8 LIKE 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL ISOLATION; CELL SURFACE; COCULTURE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DOWN REGULATION; GENE ACTIVATION; IMMUNE RESPONSE; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN; SUPERNATANT; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SEPARATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE KNOCKDOWN TECHNIQUES; IMMUNE TOLERANCE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; MICE, INBRED BALB C; MICROSCOPY, CONFOCAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; T-LYMPHOCYTES, REGULATORY;

MURINAE; MUS;

EID: 82455192387     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2011.08.016     Document Type: Article

References (36)

1. Akdis M. Healthy immune response to allergens: T regulatory cells and more. Curr. Opin. Immunol. 2006, 18(6):738-744.
2. Akdis M., Akdis C.A. Mechanisms of allergen-specific immunotherapy. J. Allergy Clin. Immunol. 2007, 119(4):780-791.
3. Asano M., Toda M., Sakaguchi N., Sakaguchi S. Autoimmune disease as a consequence of developmental abnormality of a T-cell subpopulation. J. Exp. Med. 1996, 184(2):387-396.
4. Becker C., Fantini M.C., Neurath M.F. TGF-beta as a T cell regulator in colitis and colon cancer. Cytokine Growth Factor Rev. 2006, 17(1-2):97-106.
5. + regulatory T cells control Leishmania major persistence and immunity. Nature 2002, 420(6915):502-507.
6. Belkaid Y., Rouse B.T. Natural regulatory T cells in infectious disease. Nat. Immunol. 2005, 6(4):353-360.
7. + T regulatory cells. J. Immunol. 2005, 175(12):8051-8059.
8. Decker E.L., Nehmann N., Kampen E., Eibel H., Zipfel P.F., Skerka C. Early growth response proteins (EGR) and nuclear factors of activated T cells (NFAT) form heterodimers and regulate proinflammatory cytokine gene expression. Nucleic Acids Res. 2003, 31(3):911-921.
9. + regulatory T cells: differentiation, specification, subphenotypes. Nat. Immunol. 2009, 10(7):689-695.
10. + regulatory T cells. Nat. Immunol. 2003, 4(4):330-336.
11. Fontenot J.D., Rasmussen J.P., Williams L.M., Dooley J.L., Farr A.G., Rudensky A.Y. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 2005, 22(3):329-341.
12. Hoffman B.E., Martino A.T., Sack B.K., Cao O., Liao G., Terhorst C., Herzog R.W. Nonredundant roles of IL-10 and TGF-beta in suppression of immune responses to hepatic aav-factor ix gene transfer. Mol. Ther. 2011, [Epub ahead of print].
13. Hori S., Sakaguchi S. Foxp3: a critical regulator of the development and function of regulatory T cells. Microbes Infect. 2004, 6(8):745-751.
14. Huang L.F., Yao Y.M., Zhang L.T., Dong N., Yu Y., Sheng Z.Y. The effect of high-mobility group box 1 protein on activity of regulatory T cells after thermal injury in rats. Shock 2009, 31(3):322-329.
15. Iwasaka H., Noguchi T. Th1/Th2 balance in systemic inflammatory response syndrome (SIRS). Nippon Rinsho 2004, 62(12):2237-2243.
16. Jacobson E.A., Hutchinson K., Inch W.R., Tustanoff E.R. Ultrastructural changes in V79 hamster lung fibroblasts during hypoxic exposure. Virchows Arch. B: Cell. Pathol. Incl. Mol. Pathol. 1985, 49(1):23-43.
17. + T cells with regulatory properties isolated from peripheral blood. J. Exp. Med. 2001, 193(11):1285-1294.
18. + T cell cytotoxicity and cancer. Semin. Cancer Biol. 2006, 16(2):124-136.
19. Kumar D., Gokhale P., Broustas C., Chakravarty D., Ahmad I., Kasid U. Expression of SCC-S2, an antiapoptotic molecule, correlates with enhanced proliferation and tumorigenicity of MDA-MB 435 cells. Oncogene 2004, 23(2):612-616.
20. Kumar D., Whiteside T.L., Kasid U. Identification of a novel tumor necrosis factor-alpha-inducible gene, SCC-S2, containing the consensus sequence of a death effector domain of fas-associated death domain-like interleukin-1beta-converting enzyme-inhibitory protein. J. Biol. Chem. 2000, 275(4):2973-2978.
21. Larche M., Akdis C.A., Valenta R. Immunological mechanisms of allergen-specific immunotherapy. Nat. Rev. Immunol. 2006, 6(10):761-771.
22. Li D., Song L., Fan Y., Li X., Li Y., Chen J., Zhu F., Guo C., Shi Y., Zhang L. Down-regulation of TIPE2 mRNA expression in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Clin. Immunol. 2009, 133(3):422-427.
23. + dendritic cells to acquire potent indoleamine 2,3-dioxygenase-dependent T cell regulatory functions via IFN Type 1 signaling. J. Immunol. 2005, 175(9):5601-5605.
24. Nakano N., Hosokawa H., Kohyama M., Hozumi N. NF-AT-mediated expression of TGF-beta1 in tolerant T cells. J. Immunol. 2007, 178(5):3067-3075.
25. Patel S., Wang F.H., Whiteside T.L., Kasid U. Identification of seven differentially displayed transcripts in human primary and matched metastatic head and neck squamous cell carcinoma cell lines: implications in metastasis and/or radiation response. Oral Oncol. 1997, 33(3):197-203.
26. + suppressor T cells regulate pathogen induced inflammation and disease. FEMS Immunol. Med. Microbiol. 2005, 44(2):121-127.
27. + regulatory T cells in self-tolerance and autoimmune disease. Curr. Top. Microbiol. Immunol. 2006, 305:51-66.
28. Singh M.P., Rai A.K., Singh S.M. Gender dimorphism in the progressive in vivo growth of a T cell lymphoma: involvement of cytokines and gonadal hormones. J. Reprod. Immunol. 2005, 65(1):17-32.
29. + T-cell lymphopenia-induced proliferation. Eur. J. Immunol. 2009, 39(6):1544-1551.
30. Sun H., Gong S., Carmody R.J., Hilliard A., Li L., Sun J., Kong L., Xu L., Hilliard L., Hu S., Shen H., Yang X., Chen Y.H. TIPE2, a negative regulator of innate and adaptive immunity that maintains immune homeostasis. Cell 2008, 133(3):415-426.
31. + T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J. Immunol. 1998, 160(3):1212-1218.
32. Yoshinaga-Hirabayashi T., Yoneda Y. Expression of SCC in ovarian granulosa cells and cultured cells, induced rapid structural changes in mitochondria. Ital. J. Anat. Embryol. 2001, 106(2 Suppl 1):51-57.
33. Zhang C., Chakravarty D., Sakabe I., Mewani R.R., Boudreau H.E., Kumar D., Ahmad I., Kasid U.N. Role of SCC-S2 in experimental metastasis and modulation of VEGFR-2, MMP-1, and MMP-9 expression. Mol. Ther. 2006, 13(5):947-955.
34. Zhang G., Hao C., Lou Y., Xi W., Wang X., Wang Y., Qu Z., Guo C., Chen Y., Zhang Y., Liu S. Tissue-specific expression of TIPE2 provides insights into its function. Mol. Immunol. 2010, 47(15):2435-2442.
35. Zhang X., Wang J., Fan C., Li H., Sun H., Gong S., Chen Y.H., Shi Y. Crystal structure of TIPE2 provides insights into immune homeostasis. Nat. Struct. Mol. Biol. 2009, 16(1):89-90.
36. Zhang Y., Yao Y.M., Huang L.F., Dong N., Yu Y., Sheng Z.Y. The potential effect and mechanism of high-mobility group box 1 protein on regulatory T cell-mediated immunosuppression. J. Interferon Cytokine Res. 2011, 31(2):249-257.